An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 687 - 693 of 912
Exposure to common insecticides associated with risk of death
People with higher exposures to common insecticides called pyrethroids had an increased risk of death in the years following the measurements.
Understanding allergic reactions to skin care products
A laboratory study gave new insight into how skin creams, cosmetics, and fragrances may cause immune responses that lead to rashes in some people.
Blood protein signatures change across lifespan
Blood levels of around 400 proteins accurately reflected people’s age and relative health. Such a protein signature might help identify people at greater risk of age-related diseases.
Immune cell metabolism altered in ME/CFS
Scientists found that some immune cells in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show disruptions in the way they produce and use energy.
Researchers find cause of new autoinflammatory disease
Researchers found that mutations in a specific gene cause a previously unknown autoinflammatory disease, which they’ve named CRIA syndrome.
2019 Research Highlights - Human Health Advances
NIH accomplishments in disease prevention, diagnosis, and treatment include treatments for the Ebola virus, gene therapy that reverses a rare immune disorder, and a blood test to detect myalgic encephalomyelitis/chronic fatigue syndrome
2019 Research Highlights - Promising Medical Findings
NIH findings with potential for enhancing human health include a way to predict which people at risk for psychosis may progress to full psychosis, insights into recurrent tonsillitis, and a patch to replace damaged retinal cells.